If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

FY25 Trading Update

28 Apr 2025 07:00

RNS Number : 2977G
Marlowe PLC
28 April 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

28 April 2025

 

Marlowe plc

("Marlowe" or the "Group")

 

FY25 Trading Update

 

Marlowe plc, the leader in business-critical services, provides a trading update ahead of publication of the Group's full year results for the year ended 31 March 2025 ("FY25").

 

The Group also announces the bolt-on acquisition of Sludge Tek Holdings Limited and one of its trading subsidiaries, Sludge Tek Limited (together "SludgeTek"), a leading specialist in wastewater services.

 

FY25 Trading Update

 

Marlowe has delivered strong financial and strategic progress in FY25. During the period, the Group successfully completed the divestment of selected Governance, Risk and Compliance ("GRC") software and service assets for an enterprise value of £430 million, and following this transaction, returned £150 million to Group shareholders by way of a special dividend paid on 5 July 2024. In addition, the Group launched a £75 million share buyback programme on 22 May 2024, which is now nearing completion.

 

In September 2024, the Group completed the demerger of its Occupational Health division, resulting in the formation of Optima Health plc, a separately listed entity. Following this transaction, Marlowe's continuing operations are now focused exclusively on the attractive Testing, Inspection and Certification ("TIC") markets, comprising market-leading businesses in both Water & Air Hygiene and Fire Safety & Security.

 

The Group's continuing operations are expected to deliver FY25 revenue of approximately £305.0 million and adjusted EBITDA1 of approximately £32.5 million (after £4.2 million of head office costs), both in line with market expectations2. Adjusted profit before tax1 is expected to be ahead of market expectations2 at approximately £18.5 million.

 

At 31 March 2025, Marlowe had a net cash position (excluding IFRS lease liabilities) of approximately £22 million, reflecting strong cash generation ahead of market expectations in the period and progress made on the share buyback programme which returned an aggregate of £66 million to Marlowe shareholders over the course of FY25. As at 31 March 2025, the Group's £50m debt facility remained undrawn.

 

As previously announced, the Group has made strong progress with its integration programme, with all restructuring activity and associated costs related to continuing operations concluded by 30 September 2024, in line with previous guidance. As part of the finalisation of this process, the Group undertook a detailed review of certain balance sheet items within the Water & Air Hygiene segment, which is expected to result in a revision of approximately £3.1 million in non-cash adjusting items at 31 March 2025. The revision primarily relates to the reassessment of the recoverability of certain aged balances, and while this will result in a one-off FY25 impact, there is no impact upon the ongoing trading performance or future cash generation of the business.

 

Acquisition of SludgeTek

As previously announced, the TIC service markets remain highly fragmented and notwithstanding the Group's primary focus in the near term remaining on driving margin enhancement and organic growth, bolt-on acquisitions continue to present an attractive route for the Group to deliver additional shareholder value.

The Company is therefore also pleased to announce the acquisition of SludgeTek for an expected enterprise value of £6.2 million (the "Acquisition"). Headquartered in Andover and established in 2001, SludgeTek provides specialist services to the Waste Management and Manufacturing sectors.

In the year ended 30 September 2024, SludgeTek generated revenue and adjusted EBITDA1 of £5.3 million and £1.7 million respectively and the consideration for the acquisition consists of an initial payment of £5.7 million, and deferred consideration of an estimated £0.5 million based on the completion of certain post-acquisition performance targets objectives.

The Acquisition further strengthens Marlowe's position as a leading provider of wastewater rental solutions and is highly complementary to the Group's existing capabilities. The business is expected to be easily integrated into the Group's operations, and Marlowe does not anticipate any associated restructuring costs to be reported in connection with the transaction.

The Group continues to actively assess further bolt-on acquisition opportunities across both Water & Air Hygiene and Fire Safety & Security, consistent with its strategy to build scale and consolidate market leadership in these attractive and resilient sectors.

1Adjusted measures are presented before acquisition and disposal costs, restructuring costs, amortisation of acquired intangibles, share-based payments and legacy long-term incentives, as well as fair value losses in contingent consideration and the one-off revision to balance sheet items noted above.

2Analyst consensus prior to this announcement is for FY25 revenue of £306 million, adjusted EBITDA of £33 million and adjusted profit before tax of £16 million.

 

For further information:

 

 

 

Marlowe plc

Lord Ashcroft, Interim Non-Executive Chair

Adam Councell, Chief Financial Officer

Benjamin Tucker, Head of Group Reporting

 

www.marloweplc.com

Tel: +44 (0)20 3813 8498

IR@marloweplc.com

 

Cavendish Capital Markets Limited (Nominated Adviser & Broker)

Ben Jeynes

George Lawson

Tel: +44 (0)20 7220 0500

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIAMATMTTTBAA
Date   Source Headline
1st Jul 20227:00 amRNSPublication of Annual Report
28th Jun 20227:00 amRNSFinal Results
23rd Jun 20227:00 amRNSNotice of Full Year Results Analyst Presentation
8th Jun 20227:00 amRNSAcquisition of HR Solutions
25th May 20227:00 amRNSAcquisition of Cedrec Information Systems Limited
23rd May 202212:55 pmRNSExercise of Share Options and Total Voting Rights
28th Apr 20224:22 pmRNSHolding(s) in Company
28th Apr 20224:18 pmRNSHolding(s) in Company
26th Apr 20224:36 pmRNSExercise of Share Options and Total Voting Rights
19th Apr 20227:00 amRNSAcquisition of TP Health
11th Apr 202210:47 amRNSExercise of Share Options
5th Apr 20223:05 pmRNSCapital Markets Day Replay
5th Apr 20227:00 amRNSCapital Markets Day
22nd Mar 20227:00 amRNSAcquisition of Griffin Fire
21st Mar 20227:00 amRNSNotice of Capital Markets Day and Trading Update
15th Mar 20227:00 amRNSAppointment of Joint Corporate Broker
17th Feb 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSAcquisition of S F Fire Limited
10th Feb 20227:00 amRNSNew Enlarged Debt Facility
31st Jan 202212:20 pmRNSHolding(s) in Company
28th Jan 20222:19 pmRNSDirector/PDMR Shareholding
27th Jan 20229:07 amRNSHolding(s) in Company
26th Jan 202211:39 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSIssue of Equity and Total Voting Rights
21st Jan 20221:08 pmRNSHolding(s) in Company
20th Jan 20224:08 pmRNSResults of Placing
20th Jan 20227:48 amRNSProposed Placing and Acquisition of Optima Health
20th Jan 20227:00 amRNSAcquisition of Optima Health
19th Jan 202212:13 pmRNSAppointment of Independent Non-Executive Director
14th Jan 20225:01 pmRNSExercise of Share Options
20th Dec 20217:00 amRNSAcquisition of Skill Boosters
14th Dec 202111:12 amRNSHolding(s) in Company
1st Dec 20212:00 pmRNSHalf Year Results Presentation Replay
1st Dec 20217:00 amRNSHalf Year Results
24th Nov 20217:00 amRNSTrading Update and Notice of Results
5th Nov 20211:15 pmRNSDirectorate Change
20th Oct 20211:53 pmRNSResults of Placing and Director/PDMR Dealing
20th Oct 20217:00 amRNSAcquisition of EssentialSkillz & Proposed Placing
14th Oct 20217:00 amRNSRefinance and Acquisition Completion
13th Oct 20217:00 amRNSAppointment of Non-Executive Director
7th Oct 20217:00 amRNSAcquisition of Sterling Hydrotech
5th Oct 20217:00 amRNSFurther re CFO Appointment and Directorate Change
4th Oct 20217:00 amRNSAcquisitions of VinciWorks Legal & Hydro-X Group
15th Sep 20211:13 pmRNSResult of AGM
7th Sep 20217:00 amRNSAcquisition of Santia Limited
31st Aug 20217:00 amRNSLaunch of Group 2021 SAYE Scheme
18th Aug 20217:00 amRNSDirector Dealing, Equity Issue & Grant of Options
11th Aug 20213:20 pmRNSForm 8.3 - Marlowe Plc
11th Aug 202111:08 amRNSForm 8.5 (EPT/RI)
10th Aug 20212:34 pmRNSForm 8.3 - Marlowe plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.